Chemotherapy within 30 days before surgery does not augment postoperative mortality and morbidity

Canadian Journal of Anesthesia

Volumn 59, Issue 8, 2012, Pages 758-765

  Turan, Alparslan ^a   Shao, Diana ^a   Salmasi, Vafi ^a   Honar, Hooman ^a   Atim, Abdulkadir ^a   Dalton, Jarrod E ^a   Saager, Leif ^a   Sessler, Daniel I ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CANCER CHEMOTHERAPY; CANCER SURGERY; CHRONIC KIDNEY FAILURE; COMA; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENDOTRACHEAL INTUBATION; FEMALE; GRAFT FAILURE; HEART ARREST; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PERIPHERAL NERVE INJURY; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE MORBIDITY; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; STROKE; SURGICAL MORTALITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOPHLEBITIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOUND INFECTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DATABASES, FACTUAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TIME FACTORS;

EID: 84864436298     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-012-9735-3     Document Type: Article

References (20)

1. Kochanek KD, Xu J, Murphy SL, Minino AM, Kung HC. Deaths: Preliminary data for 2009, National Vital Statistics Reports. Hyattsville, MD, National Center for Health Statistics, 2011. Available from URL: http://www.cdc.gov/nchs/ data/nvsr/nvsr59/nvsr59-04.pdf (accessed April 2012)
2. Leong T, Guiney M, Ngan S, Mackay J. Pre-operative radiotherapy and chemotherapy for non-resectable rectal cancer. Aust N Z J Surg 1997; 67: 603-6.
3. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104-9.
4. Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003; 10: 754-61.
5. Urschel JD, Ashiku S, Thurer R, Sellke FW. Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer-a review. Dis Esophagus 2003; 16: 60-5.
6. Pisters KM, Vallieres E, Crowley JJ, et al. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol 2010; 28: 1843-9.
7. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-16.
8. Tabira Y, Okuma T, Kondo K, et al. Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity? Jpn J Thorac Cardiovasc Surg 1999; 47: 361-7.
9. Meric F, Milas M, Hunt KK, et al. Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol 2000; 18: 3378-83.
10. Malthaner RA, Collin S, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 2006; 3: CD001556.
11. Dahn D, Martell J, Vorwerk H, et al. Influence of irradiated lung volumes on perioperative morbidity and mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2010; 77: 44-52.
12. Kesmodel SB, Ellis LM, Lin E, et al. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol 2008; 26: 5254-60.
13. Fink AS, Campbell DA Jr, Mentzer RM Jr, et al. The National Surgical Quality Improvement Program in non-veterans administration hospitals: initial demonstration of feasibility. Ann Surg 2002; 236: 344-54.
14. Khuri SF. The NSQIP: a new frontier in surgery. Surgery 2005; 138: 837-43.
15. Normand ST, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 2001; 54: 387-98.
16. Cohen J. Statistica Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988 .
17. Kelley ST, Coppola D, Karl RC. Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg 2004; 8: 227-31.
18. Buie WD, MacLean AR, Attard JA, Brasher PM, Chan AK. Neoadjuvant chemoradiation increases the risk of pelvic sepsis after radical excision of rectal cancer. Dis Colon Rectum 2005; 48: 1868-74.
19. Artioukh DY, Smith RA, Gokul K. Risk factors for impaired healing of the perineal wound after abdominoperineal resection of rectum for carcinoma. Colorectal Dis 2007; 9: 362-7.
20. Shapiro R, Barsuk D, Segev L, et al. Pre-operative cardiac workup after anthracycline-based neoadjuvant chemotherapy. Is it really necessary? Ann R Coll Surg Engl 2011; 93: 127-9.